Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview

被引:29
作者
Sikdar, Nilabja [1 ]
Saha, Gourab [1 ]
Dutta, Ashmita [1 ]
Ghosh, Shibajyoti [2 ]
Shrikhande, Shailesh V. [3 ]
Banerjee, Sudeep [4 ]
机构
[1] Indian Stat Inst, Human Genet Unit, 203 BT Rd, Kolkata 700108, W Bengal, India
[2] Med Coll & Hosp, 88 Coll St, Kolkata 700073, W Bengal, India
[3] Tata Mem Hosp, Bombay 400012, Maharashtra, India
[4] Tata Med Ctr, Kolkata 700156, W Bengal, India
关键词
Pancreatic ductal adenocarcinoma; Periampullary adenocarcinoma; Familial pancreatic cancer; High frequency mutations; Low frequency mutations; Molecular carcinogenesis; PAPILLARY MUCINOUS NEOPLASMS; LONG-TERM SURVIVAL; K-RAS MUTATION; INTRAEPITHELIAL NEOPLASIA; HEREDITARY PANCREATITIS; HOMOZYGOUS DELETIONS; GERMLINE MUTATIONS; ONCOGENIC KRAS; CATIONIC TRYPSINOGEN; P53; OVEREXPRESSION;
D O I
10.2174/1389202919666180221160753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subtypes, pancreatic, Common Bile Duct (CBD), ampullary and duodenum shows relative better prognosis. The highest incidence of PDAC has been reported with black with respect to white population. Similarly, incidence rate of PAC also differs with different ethnic populations. Several lifestyle, environmental and occupational exposures including long-term diabetes, obesity, and smoking, have been linked to PDAC, however, for PAC the causal risk factors were poorly described. It is now clear that PDAC and PAC are a multi-stage process resulting from the accumulation of genomic alterations in the somatic DNA of normal cells as well as inherited mutations. Approximately 10% of PDAC have a familial inheritance. Germline mutations in CDKN2A, BRCA2, STK11, PALB2, PRSS1, etc., as well as certain syndromes have been well associated with predisposition to PDAC. KRAS, CDKN2A, TP53 and SMAD4 are the 4 "mountains" (high-frequency driver genes) which have been known to earliest somatic alterations for PDAC while relatively less frequent in PAC. Our understanding of the molecular carcinogenesis has improved in the last few years due to extensive research on PDAC which was not well explored in case of PAC. The genetic alterations that have been identified in PDAC and different subgroups of PAC are important implications for the development of genetic screening test, early diagnosis, and prognostic genetic markers. The present review will provide a brief overview of the incidence and prevalence of PDAC and PAC, mainly, increased risk in India, the several kinds of risk factors associated with the diseases as well as required genetic alterations for disease initiation and progression.
引用
收藏
页码:444 / 463
页数:20
相关论文
共 202 条
[1]   Genome-wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms [J].
Abe, Taclayoshi ;
Fukushima, Noriyoshi ;
Brune, Kieran ;
Boehm, Corinne ;
Sato, Norihiro ;
Matsubayashi, Hiroyuki ;
Canto, Marcia ;
Petersen, Gloria M. ;
Hruban, Ralph H. ;
Goggins, Michael .
CLINICAL CANCER RESEARCH, 2007, 13 (20) :6019-6025
[2]   Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma [J].
Aguirre, AJ ;
Bardeesy, N ;
Sinha, M ;
Lopez, L ;
Tuveson, DA ;
Horner, J ;
Redston, MS ;
DePinho, RA .
GENES & DEVELOPMENT, 2003, 17 (24) :3112-3126
[3]   p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer [J].
Ahrendt, SA ;
Brown, HM ;
Komorowski, RA ;
Zhu, YR ;
Wilson, SD ;
Erickson, BA ;
Ritch, PS ;
Pitt, HA ;
Demeure, MJ .
SURGERY, 2000, 128 (04) :520-528
[4]  
[Anonymous], 1993, GENEREVIEWS
[5]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[6]   The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells [J].
Asano, T ;
Yao, YX ;
Zhu, JJ ;
Li, DH ;
Abbruzzese, JL ;
Reddy, SAG .
ONCOGENE, 2004, 23 (53) :8571-8580
[7]   Absence of germline BRCA1 mutations in familial pancreatic cancer patients [J].
Axilbund, Jennifer E. ;
Argani, Pedram ;
Kamiyama, Mihoko ;
Palmisano, Emily ;
Raben, Marian ;
Borges, Michael ;
Brune, Kieran A. ;
Goggins, Michael ;
Hruban, Ralph H. ;
Klein, Alison P. .
CANCER BIOLOGY & THERAPY, 2009, 8 (02) :131-135
[8]   Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families [J].
Bartsch, D. K. ;
Langer, P. ;
Habbe, N. ;
Matthaei, E. ;
Chaloupka, B. ;
Sina, M. ;
Hahn, S. A. ;
Slater, E. P. .
CLINICAL GENETICS, 2010, 77 (04) :333-341
[9]   Familial pancreatic cancer-current knowledge [J].
Bartsch, Detlef K. ;
Gress, Thomas M. ;
Langer, Peter .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (08) :445-453
[10]   Low frequency of CHEK2 mutations in familial pancreatic cancer [J].
Bartsch, Detlef K. ;
Krysewski, Kristina ;
Sina-Frey, Mercedes ;
Fendrich, Volker ;
Rieder, Harald ;
Langer, Peter ;
Kress, Ralf ;
Schneider, Margarete ;
Hahn, Stephan A. ;
Slater, Emily P. .
FAMILIAL CANCER, 2006, 5 (04) :305-308